Fluorescent in situ hybridization as a primary test for HER2 status in breast cancer: controversies
- PMID: 20065180
- DOI: 10.1200/JCO.2009.25.1397
Fluorescent in situ hybridization as a primary test for HER2 status in breast cancer: controversies
Comment on
-
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations.J Clin Oncol. 2009 Mar 10;27(8):1323-33. doi: 10.1200/JCO.2007.14.8197. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204209 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous